Trial Profile

A Randomized, Assessor-blind Trial Comparing MENOPUR (Menotropins for Injection) and Recombinant FSH (Follicle Stimulating Hormone) in a GnRH Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 17 Feb 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

14 Oct 2021 According to a Ferring Pharmaceuticals media release, a sub analysis of data from the study will be presented at the American Society for Reproductive Medicine (ASRM) 2021 Scientific Congress & Expo.
21 Oct 2020 Results of post hoc analysis presented at the American Society for Reproductive Medicine Scientific Congress 2020
21 Oct 2020 Results of post-hoc analysis assessing possible interactions between treatment groups (HP-hMG or rFSH) and ovarian reserve presented at the American Society for Reproductive Medicine Scientific Congress 2020

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com